EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.22.43 | Neoplasms |
33298139 |
Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
1
4
2 |
| 3.4.22.43 | Neuroblastoma |
22393040 |
Human cathepsin V protease participates in the production of enkephalin and NPY neurotransmitters. |
ongoing research
unassigned |
3
0 |
| 3.4.22.43 | Placenta Accreta |
30759440 |
Possible Association between Cathepsin V and the Development of Placenta Accreta Spectrum Disorders. |
ongoing research
unassigned |
2
0 |
| 3.4.22.43 | Psoriasis |
19438477 |
The cystatin M / E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
4
1
0 |
| 3.4.22.43 | Sarcoidosis, Pulmonary |
25252891 |
Endostatin and cathepsin-V in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. |
causal interaction
diagnostic usage
unassigned |
3
2
0 |
| 3.4.22.43 | Scleroderma, Systemic |
23287360 |
Decreased cathepsin V expression due to Fli1 deficiency contributes to the development of dermal fibrosis and proliferative vasculopathy in systemic sclerosis. |
causal interaction
unassigned |
3
0 |
| 3.4.22.43 | Thyroid Cancer, Papillary |
32910988 |
Significance of nuclear cathepsin V in normal thyroid epithelial and carcinoma cells. |
causal interaction
diagnostic usage
ongoing research
unassigned |
3
2
3
0 |
| 3.4.22.43 | Vascular Diseases |
28631302 |
l-Homocysteine-induced cathepsin V mediates the vascular endothelial inflammation in hyperhomocysteinaemia. |
causal interaction
unassigned |
4
0 |
